Correlation Between VanEck Pharmaceutical and Amplify ETF

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VanEck Pharmaceutical and Amplify ETF at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VanEck Pharmaceutical and Amplify ETF into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VanEck Pharmaceutical ETF and Amplify ETF Trust, you can compare the effects of market volatilities on VanEck Pharmaceutical and Amplify ETF and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VanEck Pharmaceutical with a short position of Amplify ETF. Check out your portfolio center. Please also check ongoing floating volatility patterns of VanEck Pharmaceutical and Amplify ETF.

Diversification Opportunities for VanEck Pharmaceutical and Amplify ETF

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VanEck and Amplify is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Pharmaceutical ETF and Amplify ETF Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amplify ETF Trust and VanEck Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VanEck Pharmaceutical ETF are associated (or correlated) with Amplify ETF. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amplify ETF Trust has no effect on the direction of VanEck Pharmaceutical i.e., VanEck Pharmaceutical and Amplify ETF go up and down completely randomly.

Pair Corralation between VanEck Pharmaceutical and Amplify ETF

Considering the 90-day investment horizon VanEck Pharmaceutical ETF is expected to under-perform the Amplify ETF. But the etf apears to be less risky and, when comparing its historical volatility, VanEck Pharmaceutical ETF is 1.23 times less risky than Amplify ETF. The etf trades about -0.1 of its potential returns per unit of risk. The Amplify ETF Trust is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest  2,057  in Amplify ETF Trust on August 31, 2024 and sell it today you would earn a total of  148.00  from holding Amplify ETF Trust or generate 7.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

VanEck Pharmaceutical ETF  vs.  Amplify ETF Trust

 Performance 
       Timeline  
VanEck Pharmaceutical ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.
Amplify ETF Trust 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amplify ETF Trust are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly sluggish basic indicators, Amplify ETF showed solid returns over the last few months and may actually be approaching a breakup point.

VanEck Pharmaceutical and Amplify ETF Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VanEck Pharmaceutical and Amplify ETF

The main advantage of trading using opposite VanEck Pharmaceutical and Amplify ETF positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VanEck Pharmaceutical position performs unexpectedly, Amplify ETF can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amplify ETF will offset losses from the drop in Amplify ETF's long position.
The idea behind VanEck Pharmaceutical ETF and Amplify ETF Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency